Clinical and epidemiological characteristics of severe community-acquired pneumonia in children after introduction of the 10-valent pneumococcal vaccine

Ítems similars

• Risk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control study
  per: Fonseca Lima, Eduardo Jorge da, et al.
  Publicat: (2016)
• Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
  per: da Silva, Sandra Rodrigues, et al.
  Publicat: (2016)
• Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan
  per: Takeuchi, N., et al.
  Publicat: (2020)
• Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia
  per: Negash, Abel Abera, et al.
  Publicat: (2019)
• Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults
  per: Isturiz, Raul, et al.
  Publicat: (2015)